First ABO ‐Incompatible Pediatric Kidney Transplant in South Africa—A Case Report
Pediatric Transplantation · 2025
DOI: 10.1111/petr.70000 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Ashton Coetzee und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Cape Town, Cape Town, South Africa. Hauptthemen laut MEDLINE: Kidney Transplantation, ABO Blood-Group System, Blood Group Incompatibility, Kidney Failure, Chronic. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Blood group incompatibility previously represented an obstacle to living related donor (LRD) options; desensitization modalities have expanded LRD options. ABO‐incompatible kidney transplants have been successful in adults and pediatric liver transplants, but to date not yet in pediatric kidney transplants in South Africa. Case Report Patient X is a 5 year old male with end‐stage kidney failure due to Posterior Urethral Valves, requiring peritoneal dialysis pre‐transplant. His sister was the only suitable LRD. The recipient was blood group A+; donor was blood group B+; HLA match was 5/10, nil HLA donor specific antibodies and negative CDC and Flow crossmatches. The recipients' anti‐B titer pre‐transplant was a maximum of 1:8. A pre‐emptive desensitization dose of Rituximab (375 mg/m 2 ) was administered 4 weeks before transplant. The anti‐B titer decreased to 1:2 following the Rituximab (CD19% of 0%). Post‐transplant, the Anti‐B titers were monitored for the first 10 days, with a maximum titer of 1:8 (immunoadsorbtion therapy available if > 1:16, or if associated graft dysfunction). Immunosuppressant protocol consisted of Basiliximab, Tacrolimus, Azathioprine, and Prednisone. Post‐transplant, the creatinine improved to 60–70 μmol/L at Week 1. 7 weeks post‐transplant, serum creatinine increased > 10% with an antibody titer of 1:2. Kidney biopsy showed CNI‐related toxicity; renal function improved with reduction in Tacrolimus doses. Kidney function remains stable 1‐year post‐transplant with nil episodes of rejection.
Conclusion
This is the first ABO‐incompatible kidney transplant in a pediatric patient in South Africa and represents an important step in expanding the pool of potential living related donors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Cape Town, Cape Town, South Africa.
- Red Cross Children's War Memorial Hospital, Cape Town, South Africa.
- Groote Schuur Hospital, Cape Town, South Africa.
ORCID-Profile: Ashton Coetzee, Peter Nourse, Tinus Du Toit, Dave Thomson, Zunaid A Barday, Mignon I McCulloch
Zitieren
APA
Coetzee, A., Nourse, P., Abdo, T., Pienaar, T., Siyothula, T., Du Toit, T., Thomson, D., Barday, Z. A., Ndamase, B., & McCulloch, M. I. (2025). First ABO ‐Incompatible Pediatric Kidney Transplant in South Africa—A Case Report. Pediatric Transplantation. https://doi.org/10.1111/petr.70000
Vancouver
Coetzee A, Nourse P, Abdo T, Pienaar T, Siyothula T, Du Toit T, et al. First ABO ‐Incompatible Pediatric Kidney Transplant in South Africa—A Case Report. Pediatric Transplantation. 2025. doi:10.1111/petr.70000
BibTeX
@article{Coetzee2025,
author = {Coetzee, Ashton and Nourse, Peter and Abdo, Theresa and Pienaar, Taryn and Siyothula, Thozama and Du Toit, Tinus and Thomson, Dave and Barday, Zunaid A and Ndamase, Bongiswa and McCulloch, Mignon I},
title = {First ABO ‐Incompatible Pediatric Kidney Transplant in South Africa—A Case Report},
journal = {Pediatric Transplantation},
year = {2025},
doi = {10.1111/petr.70000}
}
EUVIMED